Greenwich LifeSciences Inc (GLSI)
14.07
-0.38
(-2.63%)
USD |
NASDAQ |
May 17, 16:00
14.07
0.00 (0.00%)
After-Hours: 20:00
Greenwich LifeSciences Total Liabilities (Quarterly): 0.2944M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.2944M |
| September 30, 2023 | 0.2973M |
| June 30, 2023 | 0.3015M |
| March 31, 2023 | 0.2356M |
| December 31, 2022 | 0.2629M |
| September 30, 2022 | 0.2379M |
| June 30, 2022 | 0.2291M |
| March 31, 2022 | 0.2412M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.3852M |
| September 30, 2021 | 0.4551M |
| June 30, 2021 | 0.6526M |
| March 31, 2021 | 0.6731M |
| December 31, 2020 | 1.046M |
| September 30, 2020 | 1.616M |
| June 30, 2020 | 1.738M |
| December 31, 2019 | 1.377M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2291M
Minimum
Jun 2022
1.738M
Maximum
Jun 2020
0.6277M
Average
0.3434M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 51.05B |
| Outlook Therapeutics Inc | 193.26M |
| Gain Therapeutics Inc | 5.935M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.995M |
| Shareholders Equity (Quarterly) | 6.700M |